Cocrystal Pharma
Price & Volume
Stats
See more52W Range | $0.76-$2.03 |
Market Cap | $14.8M |
Shares Short | 395,023 |
Financials
See moreRevenue (12 Mos) | $225,000 |
Revenue Growth (YoY) | 26.9% |
Gross Profit (12 Mos) | -$4.8M |
Diluted EPS | -$0.73 |
News
See moreYahoo Finance • 9 days ago
Cocrystal Pharma Announces $5 Million Private Placement with OPKO Health
Yahoo Finance • 3 months ago
Cocrystal Pharma Provides Business Update and Reports First Quarter 2026 Financial Results
Yahoo Finance • 6 months ago
Cocrystal Pharma’s First Oral Norovirus Protease Inhibitor CDI-988 to be Featured at the International Society for Antiviral Research Conference (ICAR) 2026
Yahoo Finance • 8 months ago
Cocrystal Pharma to Present at the Noble Capital Markets’ 21st Emerging Growth Equity Conference
About
CFO | Mr. James J. Martin CPA, M.B.A. |
Address | 19805 North Creek Parkway, Bothell, WA, United States, 98011 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 10 |